share_log

Greif Analyst Ratings

Benzinga ·  Aug 31, 2023 10:37
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/31/2023 30.63% Stifel → $94 Reiterates Buy → Buy
07/10/2023 B of A Securities Upgrades Underperform → Neutral
06/09/2023 -6.89% Wells Fargo $66 → $67 Maintains Equal-Weight
06/02/2023 -8.28% Wells Fargo $69 → $66 Maintains Equal-Weight
11/30/2022 -4.11% Wells Fargo $63 → $69 Maintains Equal-Weight
10/31/2022 -13.84% BMO Capital $72 → $62 Downgrades Market Perform → Underperform
10/13/2022 -6.89% B of A Securities $80 → $67 Downgrades Buy → Underperform
10/06/2022 -12.45% Wells Fargo $71 → $63 Maintains Equal-Weight
09/06/2022 -1.33% Wells Fargo → $71 Downgrades Overweight → Equal-Weight
09/06/2022 -2.72% BMO Capital $52 → $70 Upgrades Underperform → Market Perform
09/02/2022 25.07% Stifel → $90 Initiates Coverage On → Buy
06/13/2022 1.45% Wells Fargo $71 → $73 Maintains Overweight
02/15/2022 -1.33% Wells Fargo → $71 Upgrades Equal-Weight → Overweight
01/12/2022 -9.67% Wells Fargo $75 → $65 Maintains Equal-Weight
12/15/2021 -4.11% B of A Securities $77 → $69 Downgrades Neutral → Underperform
12/10/2021 -19.4% Keybanc $63 → $58 Maintains Underweight
11/29/2021 4.22% Wells Fargo $79 → $75 Downgrades Overweight → Equal-Weight
11/12/2021 -1.33% BMO Capital → $71 Downgrades Outperform → Market Perform
10/14/2021 7% B of A Securities → $77 Downgrades Buy → Neutral
09/03/2021 -20.79% Keybanc $55 → $57 Maintains Underweight
08/16/2021 -23.57% Keybanc $50 → $55 Maintains Underweight
04/05/2021 -37.47% Keybanc $40 → $45 Maintains Underweight
10/12/2020 -31.91% BMO Capital $38 → $49 Upgrades Market Perform → Outperform
09/23/2020 -47.19% BMO Capital $32 → $38 Upgrades Underperform → Market Perform
09/21/2020 -36.08% B of A Securities → $46 Upgrades Underperform → Buy
06/05/2020 -36.08% Wells Fargo $42 → $46 Maintains Overweight
05/08/2020 -63.87% Keybanc $29 → $26 Maintains Underweight
04/09/2020 -41.63% Wells Fargo $47 → $42 Maintains Overweight
04/09/2020 -59.7% Keybanc $31 → $29 Maintains Underweight
02/28/2020 -44.41% Baird $45 → $40 Maintains Neutral
01/14/2020 -27.74% Wells Fargo → $52 Upgrades Equal-Weight → Overweight
12/12/2019 -49.97% BMO Capital $28 → $36 Maintains Underperform
12/06/2019 -36.08% Wells Fargo $40 → $46 Maintains Market Perform
12/06/2019 -37.47% Baird $40 → $45 Maintains Neutral
12/21/2018 -41.63% Baird $55 → $42 Maintains Outperform
12/21/2018 BMO Capital Downgrades Outperform → Underperform
12/21/2018 -49.97% Wells Fargo $53 → $36 Downgrades Outperform → Market Perform
12/21/2018 -56.92% Keybanc $40 → $31 Maintains Underweight
12/07/2018 -26.35% Wells Fargo $65 → $53 Maintains Outperform

What is the target price for Greif (GEF)?

The latest price target for Greif (NYSE: GEF) was reported by Stifel on August 31, 2023. The analyst firm set a price target for $94.00 expecting GEF to rise to within 12 months (a possible 30.63% upside). 11 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Greif (GEF)?

The latest analyst rating for Greif (NYSE: GEF) was provided by Stifel, and Greif reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Greif (GEF)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Greif, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Greif was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.

Is the Analyst Rating Greif (GEF) correct?

While ratings are subjective and will change, the latest Greif (GEF) rating was a reiterated with a price target of $0.00 to $94.00. The current price Greif (GEF) is trading at is $71.96, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment